entertainment -WSS

entertainment

author：hotspot 2025-08-19 12:07:51 - browse：1

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Congress: Prevent baby formula shortages by passing a new bill

focus

WSS

Some medical students still think black patients feel less pain

FogPharma raises $145 million in rare Series E round

AstraZeneca loses challenge to Medicare drug price negotiation

Congress: Prevent baby formula shortages by passing a new bill

Hospitals need to get ahead of regulations on climate change

House looks to weaken Medicare negotiation

leisure time

entertainment

focus

Apple is now the first public company to be valued at $3 trillion

Covid isolation guidance eased by the CDC

Dobbs anniversary: the lost opportunity of abortion as health care

The Bio Revolution is changing business and society

As demand for Covid shots wanes, Moderna seeks its next success

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

The high cost of giving birth even with insurance

FDA does about

Wildfire smoke exposes gaps in outdoor worker protections

FDA does about

Wikipedia

Congress: Prevent baby formula shortages by passing a new bill

Protect nursing home residents from future pandemics

Obesity now affects over 1 billion people worldwide, study finds

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

hotspot

focus

leisure time

hotspot